205 results
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
1 May 24
Emergent Biosolutions Reports First Quarter 2024 Financial Results
4:44pm
under a different regulatory mechanism outside of Emergent’ s license and will be the responsibility of the SNS. Page 6 of 10
The following table
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
6 Mar 24
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
4:15pm
and (iv) it is [not] a Defaulting Lender; and (b) assumes no responsibility with respect to (i) any statements, warranties or representations made
8-K
EX-10.1
EBS
Emergent Biosolutions Inc
21 Feb 24
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
7:25am
of Employee’s duties or field of responsibility at Emergent; (c) are directly or indirectly based on Employee’s knowledge of the actual or anticipated
8-K
EX-99.1
p23iyy14
2 Oct 23
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
7:49am
8-K
5mi14ycki
8 Aug 23
Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position
7:15am
8-K
EX-99.1
9iwbnoq1q 1kr5ramve
8 Aug 23
Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position
7:15am
8-K
EX-99.1
3ccpt5
27 Jun 23
Departure of Directors or Certain Officers
7:54am
424B5
ezv9hxx
18 May 23
Prospectus supplement for primary offering
7:45am
8-K
EX-10.1
l1qwz
17 May 23
Emergent’s Statement Regarding its Amended Credit Agreement
9:32pm
8-K
EX-10.2
mm3k 8yhziljaw5b
17 May 23
Emergent’s Statement Regarding its Amended Credit Agreement
9:32pm
DEFR14A
s3m869z
24 Apr 23
Revised proxy
9:32am